Cerebrolysin Impact on Early Ischemic Stroke Rehabilitation

Cerebrolysin is a drug made from pig brain proteins and is used to treat various brain conditions, including strokes. This study aims to see how effective Cerebrolysin is in helping patients recover from moderate to severe strokes, specifically in a hospital setting in Ljubljana. The study hopes to show whether adding Cerebrolysin to the usual care for stroke patients can improve their recovery and reduce their neurological impairments, both when they leave the hospital and 90 days later. Participants in the study will have had a recent stroke and will either receive standard stroke care alone or standard care plus Cerebrolysin. Those receiving Cerebrolysin will be given the drug through an IV infusion daily for 10 days. The researchers will then compare the recovery progress between the two groups to determine if Cerebrolysin provides any additional benefit. This involves looking at how much their neurological symptoms improve by the time they are discharged and after three months. The study ensures that the drug is administered safely, using sterile equipment for each infusion.